tiprankstipranks
Percheron Therapeutics Director Increases Shareholding
Company Announcements

Percheron Therapeutics Director Increases Shareholding

Percheron Therapeutics (AU:PER) has released an update.

Pick the best stocks and maximize your portfolio:

Percheron Therapeutics Limited announced a change in the shareholding of its director, James Garner, who has acquired an additional 375,000 ordinary shares through participation in the company’s Share Purchase Plan. This acquisition raises Garner’s total holding to 1,375,000 shares, reflecting continued confidence in the company’s prospects.

For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskPercheron Therapeutics Announces Cessation of Securities
TipRanks Australian Auto-Generated NewsdeskPercheron Therapeutics: Shareholding Increase Sparks Investor Interest
TipRanks Australian Auto-Generated NewsdeskPercheron Therapeutics Halts Avicursen Trial Amid Disappointing Results
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App